AURA
Price
$5.26
Change
+$0.20 (+3.95%)
Updated
Jan 14 closing price
Capitalization
334.03M
75 days until earnings call
Intraday BUY SELL Signals
ITRM
Price
$0.33
Change
-$0.01 (-2.94%)
Updated
Jan 14 closing price
Capitalization
17.37M
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AURA vs ITRM

Header iconAURA vs ITRM Comparison
Open Charts AURA vs ITRMBanner chart's image
Aura Biosciences
Price$5.26
Change+$0.20 (+3.95%)
Volume$165.37K
Capitalization334.03M
Iterum Therapeutics
Price$0.33
Change-$0.01 (-2.94%)
Volume$203.96K
Capitalization17.37M
AURA vs ITRM Comparison Chart in %
AURA
Daily Signal:
Gain/Loss:
ITRM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AURA vs. ITRM commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and ITRM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (AURA: $5.26 vs. ITRM: $0.33)
Brand notoriety: AURA and ITRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 85% vs. ITRM: 19%
Market capitalization -- AURA: $334.03M vs. ITRM: $17.37M
AURA [@Biotechnology] is valued at $334.03M. ITRM’s [@Biotechnology] market capitalization is $17.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 1 FA rating(s) are green whileITRM’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 1 green, 4 red.
  • ITRM’s FA Score: 1 green, 4 red.
According to our system of comparison, ITRM is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while ITRM’s TA Score has 5 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 6 bearish.
  • ITRM’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, ITRM is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -3.13% price change this week, while ITRM (@Biotechnology) price change was -9.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

AURA is expected to report earnings on Mar 31, 2026.

ITRM is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($334M) has a higher market cap than ITRM($17.4M). ITRM YTD gains are higher at: -2.687 vs. AURA (-3.486). ITRM has higher annual earnings (EBITDA): -23.2M vs. AURA (-112.21M). AURA has more cash in the bank: 162M vs. ITRM (11M). AURA has less debt than ITRM: AURA (17.8M) vs ITRM (33.7M). ITRM has higher revenues than AURA: ITRM (390K) vs AURA (0).
AURAITRMAURA / ITRM
Capitalization334M17.4M1,920%
EBITDA-112.21M-23.2M484%
Gain YTD-3.486-2.687130%
P/E RatioN/AN/A-
Revenue0390K-
Total Cash162M11M1,473%
Total Debt17.8M33.7M53%
FUNDAMENTALS RATINGS
ITRM: Fundamental Ratings
ITRM
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURAITRM
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signal:
Gain/Loss:
ITRM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FOLD14.380.06
+0.42%
Amicus Therapeutics
HEI352.29-0.01
N/A
HEICO Corp
PLBY1.87N/A
N/A
Playboy Inc
PMN8.14-0.02
-0.25%
Promis Neurosciences Inc.
YB20.24-0.07
-0.34%
Yuanbao Inc

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with NUVL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
+3.95%
NUVL - AURA
50%
Loosely correlated
+6.59%
DSGN - AURA
48%
Loosely correlated
+2.40%
XNCR - AURA
47%
Loosely correlated
+3.66%
RGNX - AURA
46%
Loosely correlated
-0.66%
BEAM - AURA
45%
Loosely correlated
+2.49%
More

ITRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with ENSC. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
-2.98%
ENSC - ITRM
38%
Loosely correlated
+0.50%
CHRS - ITRM
34%
Loosely correlated
-5.88%
ORMP - ITRM
34%
Loosely correlated
+7.37%
RGNX - ITRM
34%
Loosely correlated
-0.66%
AURA - ITRM
34%
Loosely correlated
+3.95%
More